FindTrial
Sign In

myofascial release for hyperlordosis on lumbar spine

Effectiveness of 3 Dimension myofacial releases on lumbar mobility in individuals with asymptomatic hyperlordosis : a placebo randomized controlled trail

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/03/050340
Enrollment
30
Registered
2023-03-03
Start date
Unknown
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: 3 Dimensional Myofascial Release: Individuals will be selected according to the inclusion criteria. All the individuals will be screened for hyperlordosis using flexicurve .Participants

Sponsors

Pragati Gunjal
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: healthy individuals in the age group of 18-40 years in both female and male are included in the study. Asymptomatic subject of either gender and individuals with lumbar lordosis angle more than 40degrees.

Exclusion criteria

Exclusion criteria: Individuals with spinal surgery , spinal fracture , vertebral deformity , joint diseases like facet joint arthritis , spondylolisthesis , spondylosis , radiculopathy and pregnant females.

Design outcomes

Primary

MeasureTime frame
flexicurve modified modified schober test lumbosacral angleTimepoint: baseline , 4 weeks—

Secondary

MeasureTime frame
nilTimepoint: nil—

Countries

India

Contacts

Public ContactPragati Gunjal

KAHER Institute of Physiotherapy

aartiwelling@klekipt.edu.in9632640538

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 6, 2026